Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Therapy Management and Outcomes in Newly Diagnosed Unfit AML Patients Receiving Venetoclax + HMA - Insights from a Prospective Real-World Study in Switzerland and Austria

Thomas Pabst, Thomas Lehmann, Petra Pichler, Sigrid Machherndl-Spandl, Michael Gregor, Jeroen S. Goede, Sabine Gerull, Daniel Maria Mayer, Jean-François Lambert, Catherine Germanier, Georg Stüssi

Blood (2024) 144 (Supplement 1): 2413.

https://doi.org/10.1182/blood-2024-193999

Published: 2024

Journal Articles

Inv(16) AML Engrafts Human Cytokine Knock-in Mice

Philipp J Rauch, MD, Jana M Ellegast, MD, Larisa V Kovtonyuk, PhD, Ulrich Wagner, PhD, Rouven Müller, MD, Yasuyuki Saito, MD PhD, Nicole Wildner-Verhey van Wijk, PhD, Christine Fritz, Anahita Rafiei, PhD, Veronika Lysenko, Ewa Dudkiewicz, Davide Soldini, MD PhD, Jeroen S Goede, MD, Richard Flavell, PhD, Markus G Manz, MD

Blood (2016) 128 (22): 1078.

https://doi.org/10.1182/blood.V128.22.1078.1078

Published: 2016

Journal Articles

A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in the Treatment of Anemia in Patients with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndromes (MDS)

Uwe Platzbecker, MD, Argiris Symeonidis, Esther N. Oliva, Jeroen S. Goede, Michel Delforge, Jiri Mayer, Borhane Slama, Sejal Badre, Eduard Gasal, Bhakti Mehta, Janet Franklin

Blood (2016) 128 (22): 2010.

https://doi.org/10.1182/blood.V128.22.2010.2010

Published: 2016

Journal Articles

MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia

Philipp J. Rauch, Jana M. Ellegast, Corinne C. Widmer, Kristin Fritsch, Jeroen S. Goede, Peter J. M. Valk, Bob Löwenberg, Hitoshi Takizawa, Markus G. Manz

Blood (2016) 128 (18): 2253–2257.

https://doi.org/10.1182/blood-2016-04-711986

Published: 2016

Includes: Supplemental data

Journal Articles

inv(16) and NPM1 mut AMLs engraft human cytokine knock-in mice

Jana M. Ellegast, Philipp J. Rauch, Larisa V. Kovtonyuk, Rouven Müller, Ulrich Wagner, Yasuyuki Saito, Nicole Wildner-Verhey van Wijk, Christine Fritz, Anahita Rafiei, Veronika Lysenko, Ewa Dudkiewicz, Alexandre P. Theocharides, Davide Soldini, Jeroen S. Goede, Richard A. Flavell, Markus G. Manz

Blood (2016) 128 (17): 2130–2134.

https://doi.org/10.1182/blood-2015-12-689356

Published: 2016

Includes: Supplemental data

Journal Articles

Mpl Expression on AML Blasts Predicts Cytopenia

Philipp J Rauch, MD, Corinne Widmer, MD, Kristin Fritsch, MS, Jana M Ellegast, MD, Jeroen S Goede, MD, Peter J M Valk, PhD, Hitoshi Takizawa, PhD, Markus G Manz, MD

Blood (2015) 126 (23): 1387.

https://doi.org/10.1182/blood.V126.23.1387.1387

Published: 2015

Journal Articles

Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women

Diego Moretti, Jeroen S. Goede, Christophe Zeder, Markus Jiskra, Vaiya Chatzinakou, Harold Tjalsma, Alida Melse-Boonstra, Gary Brittenham, Dorine W. Swinkels, Michael B. Zimmermann

Blood (2015) 126 (17): 1981–1989.

https://doi.org/10.1182/blood-2015-05-642223

Published: 2015

Includes: Supplemental data

Journal Articles

Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation

Hermann Heimpel, Klaus Schwarz, Monika Ebnöther, Jeroen S. Goede, Detlev Heydrich, Torsten Kamp, Lothar Plaumann, Bettina Rath, Jochen Roessler, Otto Schildknecht, Mathias Schmid, Walter Wuillemin, Beate Einsiedler, Rosi Leichtle, Hannah Tamary, Elisabeth Kohne

Blood (2006) 107 (1): 334–340.

https://doi.org/10.1182/blood-2005-01-0421

Published: 2006

Journal Articles

Oral Low Dose Etoposide in the Treatment of Macrophage Activation Syndrome.

Jeroen S. Goede, MD, Pietro E. Peghini, MD, Jorg Fehr, MD

Blood (2004) 104 (11): 3817.

https://doi.org/10.1182/blood.V104.11.3817.3817

Published: 2004

Journal Articles

Glucose-6-phosphate dehydrogenase (G6PD) deficiency–type Zurich: a splice site mutation as an uncommon mechanism producing enzyme deficiency

Thomas Efferth, Esther B. Bachli, Sonja M. Schwarzl, Jeroen S. Goede, Carol West, Jeremy C. Smith, Ernest Beutler

Blood (2004) 104 (8): 2608.

https://doi.org/10.1182/blood-2004-06-2135

Published: 2004

NARROW

Therapy Management and Outcomes in Newly Diagnosed Unfit AML Patients Receiving Venetoclax + HMA - Insights from a Prospective Real-World Study in Switzerland and Austria

Inv(16) AML Engrafts Human Cytokine Knock-in Mice

A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in the Treatment of Anemia in Patients with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndromes (MDS)

MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia

inv(16) and NPM1 mut AMLs engraft human cytokine knock-in mice

Mpl Expression on AML Blasts Predicts Cytopenia

Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women

Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation

Oral Low Dose Etoposide in the Treatment of Macrophage Activation Syndrome.

Glucose-6-phosphate dehydrogenase (G6PD) deficiency–type Zurich: a splice site mutation as an uncommon mechanism producing enzyme deficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only